Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Arno Therapeutics, Inc | v435776_s1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No. 1 to the Registration Statement No. 333-210102 of Arno Therapeutics, Inc. on Form S-1 of our report dated March 30, 2016, which included an emphasis of matter paragraph regarding the Company’s ability to continue as a going concern, on the financial statements of Arno Therapeutics, Inc. and to the reference to us under the heading “Experts” in the prospectus.
/s/ Crowe Horwath LLP
New York, New York
April 1, 2016